Notably, we observed CAD-Asp1371 mutations in GC tissues from human patients; the mutation abundance accounts for approximately 15% in patients who failed neoadjuvant or adjuvant chemotherapy, potentially explaining the absence of CAD D1371 mutation in the Catalogue of Somatic Mutations in Cancer (COSMIC) database. This evidence concerns the gene CAD and gastric cancer.